Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction—Reply

Abstract

COMMENT & RESPONSEIn Reply In their letter to the editor, Drs Asham and Entezari-Maleki inquire about the TIMI and GRACE risk scores of patients enrolled in our recent study on Tongxinluo. 1 The Table shows the similarity in the distribution of TIMI and GRACE scores at baseline, and the benefit of Tongxinluo in 30-day major adverse cardiac and cerebrovascular events across low-, intermediate-, and high-risk subgroups (all P values for interaction > .05).In response to the letter by Dr Zakiev and colleagues about the stability of the effect of Tongxinluo, the ultra-performance liquid chromatography fingerprint for 10 different batches of Tongxinluo capsules was provided in eFigure 1 of Supplement 2 of the article. 1 This eFigure showed the stability of the Tongxinluo capsule ingredients. 2